These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34222283)

  • 1. Propensity for Calcification in Serum Associates With 2-Year Cardiovascular Mortality in Ischemic Heart Failure With Reduced Ejection Fraction.
    Bojic M; Koller L; Cejka D; Niessner A; Bielesz B
    Front Med (Lausanne); 2021; 8():672348. PubMed ID: 34222283
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population: The PREVEND Study.
    Eelderink C; Te Velde-Keyzer CA; Frenay AS; Vermeulen EA; Bachtler M; Aghagolzadeh P; van Dijk PR; Gansevoort RT; Vervloet MG; Hillebrands JL; Bakker SJL; van Goor H; Pasch A; de Borst MH;
    Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1942-1951. PubMed ID: 32493170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review.
    Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcification Propensity and Survival among Renal Transplant Recipients.
    Keyzer CA; de Borst MH; van den Berg E; Jahnen-Dechent W; Arampatzis S; Farese S; Bergmann IP; Floege J; Navis G; Bakker SJ; van Goor H; Eisenberger U; Pasch A
    J Am Soc Nephrol; 2016 Jan; 27(1):239-48. PubMed ID: 25925688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.
    Koller L; Kleber ME; Brandenburg VM; Goliasch G; Richter B; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; Berger R; Mörtl D; Hülsmann M; Pacher R; März W; Niessner A
    Circ Heart Fail; 2015 Nov; 8(6):1059-67. PubMed ID: 26273098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcification Propensity of Serum is Independent of Excretory Renal Function.
    Bielesz B; Reiter T; Marculescu R; Gleiss A; Bojic M; Kieweg H; Cejka D
    Sci Rep; 2017 Dec; 7(1):17941. PubMed ID: 29263429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bundy JD; Cai X; Scialla JJ; Dobre MA; Chen J; Hsu CY; Leonard MB; Go AS; Rao PS; Lash JP; Townsend RR; Feldman HI; de Boer IH; Block GA; Wolf M; Smith ER; Pasch A; Isakova T;
    Am J Kidney Dis; 2019 Jun; 73(6):806-814. PubMed ID: 30935773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Bojic M; Bielesz B; Cejka D; Schernthaner GH; Höbaus C
    Thromb Haemost; 2022 Jun; 122(6):1040-1046. PubMed ID: 34719013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcification propensity and its association with biochemical parameters and bone mineral density in hemodialysis patients.
    Kim H; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Jung JY
    Kidney Res Clin Pract; 2023 Mar; 42(2):262-271. PubMed ID: 36328988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum calcification propensity in type 1 diabetes associates with mineral stress.
    van Dijk PR; Hop H; Waanders F; Mulder UJ; Pasch A; Hillebrands JL; van Goor H; Bilo HJG
    Diabetes Res Clin Pract; 2019 Dec; 158():107917. PubMed ID: 31697993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients.
    Lorenz G; Steubl D; Kemmner S; Pasch A; Koch-Sembdner W; Pham D; Haller B; Bachmann Q; Mayer CC; Wassertheurer S; Angermann S; Lech M; Moog P; Bauer A; Heemann U; Schmaderer C
    Sci Rep; 2017 Oct; 7(1):13368. PubMed ID: 29042624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
    Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
    Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical characteristics of heart failure with recovered ejection fraction].
    Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism.
    Kantauskaite M; Bolten K; Boschheidgen M; Schmidt C; Kolb T; Eckardt KU; Pasch A; Schimmöller L; Rump LC; Voelkl J; Stegbauer J
    Front Cardiovasc Med; 2022; 9():771096. PubMed ID: 35141300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.